Skip to content
    ABX
    Earnings call· Jun 2026(Q2 FY26)

    Abacus Global Management Q2 FY26 earnings call ABX

    Aug 6, 2026 Source

    Executive summary

    Abacus Global Management Q2 FY26 — Strong Longevity Fund Inflows and LifeARC Traction

    Abacus Global Management delivered strong Q2 FY26 results, marked by robust inflows into its longevity funds and significant progress with its LifeARC platform. The company is positioning itself as a leader in lifespan-linked finance, leveraging proprietary data and technology to capitalize on the $124 trillion generational wealth transfer, with a strategic focus on growing recurring fee-based revenue and expanding its asset management platform.

    Highlights

    5
    • Longevity fund inflows reached $544.2 million in H1 2026, surpassing the $500 million target for the period.

    • Adjusted net income totaled $27.1 million ($0.28 per diluted share), exceeding Q2 guidance of $24 million to $26 million.

    • Adjusted EBITDA grew 27% year-over-year to $40 million, maintaining a healthy 55% margin.

    • Capital deployed in Q2 was $197.9 million, a 62% increase year-over-year, with average realized gain on policy sales at 25%.

    • Launched the ABX Longevity Growth and Income Fund (ABXGX), the first registered interval fund dedicated to the longevity asset class.

    Concerns

    1
    • Asset management fees were lower due to a decline in AUM in ETF strategies, driven by market conditions and outflows.

    Guidance & targets

    8
    CategoryTargetConfidence
    Adjusted Net Income
    $26 million to $28 million
    high materiality
    High
    Adjusted EPS
    $0.26 to $0.28 per share
    high materiality
    High
    Adjusted Net Income
    $100 million to $106 million
    high materiality
    High
    Adjusted EPS
    $1 to $1.05 per share
    high materiality
    High
    Adjusted Net Income
    Top end of $100 million to $106 million
    high materiality
    High
    Adjusted EPS
    Top end of $1 to $1.05 per share
    high materiality
    High
    Capital deployed
    $150 million to $175 million
    medium materiality
    Medium
    Fee-related revenue mix
    70%
    high materiality
    High

    Operational metrics

    26
    Longevity fund inflows
    $544.2 millionsurpassing $500 million target; vs $604 million for all of 2025
    H1 FY26

    Total inflows into longevity funds for the first half of the year.

    Longevity fund inflows
    $256.1 million
    Q2 FY26

    Capital inflows into longevity funds during the second quarter.

    Capital deployed
    $197.9 millionup 62% YoY
    Q2 FY26

    Capital deployed during the second quarter.

    Capital deployed
    $362 million
    YTD FY26

    Year-to-date capital deployed.

    Qualified policies reviewed
    9,314vs 8,786 in Q1
    Q2 FY26

    Number of qualified policies reviewed by the platform.

    Total policies reviewed
    over 50,000
    YTD FY26

    Total policies reviewed year-to-date, including non-qualified, achieved with AI augmentation.

    Revenue
    $73 millionup 30% YoY
    Q2 FY26

    Total company revenue for the quarter.

    Life Solutions revenue
    $65.4 millionup 38.3% YoY
    Q2 FY26

    Revenue specifically from the Life Solutions segment.

    Technology service fees
    approaching $1 million
    YTD FY26

    Year-to-date technology service fees, in line with continued build-out and adoption.

    Total operating expense
    $42.5 millionincrease YoY
    Q2 FY26

    Increase largely driven by strategic business expenses and personnel costs from acquisitions and growth.

    Adjusted net income
    $27.1 millionabove Q2 guidance of $24 million to $26 million
    Q2 FY26

    Adjusted net income for the quarter.

    Adjusted EPS
    $0.28above Q2 guidance of $0.24 to $0.26
    Q2 FY26

    Adjusted diluted EPS for the quarter.

    Adjusted EBITDA
    $40 millionup 27% YoY
    Q2 FY26

    Adjusted EBITDA generated during the second quarter.

    Adjusted EBITDA margin
    55%
    Q2 FY26

    Adjusted EBITDA margin for the quarter.

    Cash balance
    $23.4 million
    Q2 FY26

    Cash balance at the end of the quarter.

    Policy assets
    $383 million
    Q2 FY26

    Total policy assets at quarter-end.

    Long-term debt
    $290.8 million
    Q2 FY26

    Long-term debt balance at quarter-end.

    Annualized portfolio turnover
    2xat top end of 1.5 to 2x target range
    Q2 FY26

    Annualized portfolio turnover for the quarter, reflecting demand and capital recycling.

    Average realized gain on policy sales
    25%comfortably above 20%+ long-term target
    Q2 FY26

    Average realized gain on policy sales for the quarter.

    Holding period for policies sold
    230 days
    Q2 FY26

    Average holding period for policies sold during the quarter.

    Holding period for policies on balance sheet
    153 days
    Q2 FY26

    Average holding period for policies still on the balance sheet.

    Management and servicing fees
    $6.5 million
    Q2 FY26

    Fees generated from longevity funds for the quarter.

    Fee-paying AUM
    $3.2 billion
    Q2 FY26

    Total fee-paying assets under management across the platform.

    Total AUM
    $3.5 billion
    Q2 FY26

    Total assets under management across the platform.

    Lives tracked
    over 6 millionup from 4 million QoQ
    Q2 FY26

    Number of lives tracked for mortality verification, showing significant quarter-over-quarter increase.

    Approximate tax rate
    25%
    Q2 FY26

    Approximate tax rate used for reconciling gross adjusted net income and EPS to their net equivalents.

    Industry KPIs

    3
    MetricValueDetails
    Capital returnsExpected increase%
    ROE operating ROE25%%
    Life specific when present$544.2 millionUSD

    Product announcements

    2
    ProductTypeDetails
    ABX Longevity Growth and Income Fund (ABXGX)launch
    Asset Tokenizationlaunch

    Deals & partnerships

    1
    Manning & NapierStrategic alliance to apply personalized lifespan modeling and integrate wealth management services.

    Partnership allows Manning & Napier advisors to use LifeARC. Operational integration since May, including referral channels and rolling out LifeARC across their adviser network. Proving successful in identifying value and growing advisory relationships.

    Risks & headwinds

    1
    Decline in ETF strategies AUMQ2 FY26

    Lower asset management fees

    Mitigation: Offset by robust inflows into longevity funds; focus on growing fee-based and technology revenue.

    What to watch in Q3 FY26

    5

    Capital deployed

    Q3 FY26
    Current$197.9 million in Q2
    Target$150 million to $175 million

    Why it matters

    Indicates continued strong origination and ability to put capital to work, potentially boosted by securitization efforts.

    And if we are able to move forward to the securitization in Q3 or even early Q4, but targeting Q3, as we had said on the prior call, I think that we could comfortably see that capital deployed number increase above our initial target goal of $130 million of $150 million to that $150 million to $175 million range.

    Q&A highlights

    8

    Why is full-year guidance maintained despite Q2 beat and strong Q3 guidance?

    Management is being conservative with the full-year guidance and expects to hit the top end of the range, indicating strong performance in Q4.

    Yes. Thank you for the question, Patrick. We were just staying conservative on the annual guide. We are looking towards the top end of that guide, which would put us in a really good position for Q4.

    asked by Patrick Davitt · answered by Jay Jackson

    2 min read7 chapters

    Detailed Narrative

    01

    Vision for Lifespan-Linked Finance

    Abacus aims to revolutionize asset management by leveraging personalized longevity data to inform financial planning, addressing the $124 trillion generational wealth transfer. The company positions itself as the 'intelligence layer' for lifespan-linked finance, with its origination platform serving as the 'commerce engine' and LifeARC as its 'AWS,' enabling advisors to build portfolios around real lifespans rather than generic averages.

    02

    LifeARC Platform Development and Monetization

    LifeARC, a proprietary platform that translates individual medical, genetic, and biometric data into personalized lifespan models, is gaining significant traction. It is being rolled out across Manning & Napier's adviser network and has generated substantial direct outreach from other large RIA firms. The envisioned revenue model for LifeARC is a recurring revenue share, with negotiations underway with potential partners.

    03

    Longevity Fund Growth and Interval Fund Launch

    The company achieved strong inflows into its longevity funds, raising $544.2 million in H1 2026, surpassing its $500 million target. A key milestone was the launch of the ABX Longevity Growth and Income Fund (ABXGX), the first SEC-effective registered interval fund dedicated to this asset class, which significantly expands access for individual investors and institutions seeking uncorrelated yielding products.

    04

    Origination and Capital Deployment Strength

    Abacus deployed $197.9 million of capital in Q2, marking a 62% year-over-year increase, driven by robust origination volume and strong investor appetite. The platform reviewed over 50,000 policies year-to-date, utilizing AI to enhance lead generation and review efficiency. The average realized gain on policy sales stood at 25%, comfortably above the long-term target of 20%.

    05

    Strategic Partnership with Manning & Napier

    The operational integration with Manning & Napier, initiated in May, has established a live referral channel, converting unqualified leads into wealth management clients and identifying qualified policies for settlement within their existing client base. The rollout of LifeARC across Manning & Napier's adviser network is demonstrating early proof points for a replicable playbook, with success seen in managing multimillion-dollar accounts.

    06

    Asset Tokenization Initiative

    Abacus is building an immutable on-chain record for life insurance policies, encompassing chain of title, liens, and cash flow rights. This initiative aims to enhance transparency, transferability, and investability in the secondary life insurance market, building on the strength of the company's origination platform and contributing to the growth of recurring fee-based revenue.

    07

    Balance Sheet Efficiency and Uncorrelated Returns

    The balance sheet demonstrated efficiency with an annualized portfolio turnover of 2x, at the top end of the target range. Policies sold during the quarter were held for an average of 230 days, indicating efficient capital recycling. Management emphasized the uncorrelated nature of their assets, tied to mortality rather than economic cycles, which differentiates them from private credit markets and validates their fair value marks through realized transactions.

    AI-generated summary of the company’s earnings call. Not investment advice.